Chun Kwok Au
Fortune : 222 440 $ au 30/06/2026
Fortune : 222 440 $ au 30/06/2026
Chun Kwok Au is the founder of Gt Healthcare Group, founded in 2015, serving as Managing Partner.
Current jobs include Independent Non-Executive Director at CSPC Pharmaceutical Group Ltd. since 2021, Independent Director at NovaBridge Biosciences since 2020, Member of The American Institute of Certified Public Accountants, and Associate Member of The Hong Kong Institute of Financial Analysts & Professional.
Former jobs include Independent Non-Executive Director at Simcere Pharmaceutical Group Ltd. in 2013, Independent Director at China Nepstar Chain Drugstore Ltd. from 2013 to 2016, Independent Non-Executive Director at AbelZeta Pharma, Inc., Director at JAFCO Investment (Asia Pacific) Ltd. from 2008 to 2010, Director at Morningside Group (Holdings) Ltd. from 2000 to 2005, Head-Asia Healthcare Investment Banking Group at Deutsche Bank AG from 2011 to 2012, and Partner at Ally Bridge Group HK Ltd. Education includes an undergraduate degree from The Chinese University of Hong Kong in 1995 and a graduate degree from Columbia Business School in 2007.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/03/2026 | 262 414 ( 0,14% ) | 222 440 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Directeur/Membre du Conseil | 01/01/2020 |
| CSPC PHARMACEUTICAL GROUP LIMITED | Directeur/Membre du Conseil | 27/01/2021 |
The Hong Kong Institute of Financial Analysts & Professional | Corporate Officer/Principal | - |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Gt Healthcare Group | Fondateur | 01/09/2015 |
| Sociétés | Poste | Fin |
|---|---|---|
| CHINA NEPSTAR CHAIN DRUGSTORE LTD.(ADR) | Directeur/Membre du Conseil | 01/08/2016 |
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Directeur/Membre du Conseil | 01/12/2013 |
| DEUTSCHE BANK AG | Corporate Officer/Principal | 01/12/2012 |
JAFCO Investment (Asia Pacific) Ltd.
JAFCO Investment (Asia Pacific) Ltd. Investment ManagersFinance JAFCO ASIA invests in companies located in the Asia Pacific region. The firm focuses on mobile and internet technology, consumer & services related, cyber security, medical/healthcare and renewable energy sectors. It participates in early and growth stage capital transactions. | Directeur/Membre du Conseil | 01/01/2010 |
| ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 14 |
|---|---|
Deutsche Bank AG
Deutsche Bank AG Investment Banks/BrokersFinance Provides investment and corporate banking & asset management services | Finance |
Simcere Pharmaceutical Group Ltd.
Simcere Pharmaceutical Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes branded generic drugs | Health Technology |
China Nepstar Chain Drugstore Ltd.
China Nepstar Chain Drugstore Ltd. Drugstore ChainsRetail Trade Operates drugstores | Retail Trade |
CSPC Pharmaceutical Group Ltd.
CSPC Pharmaceutical Group Ltd. BiotechnologyHealth Technology Engages in the research and development, manufacture & sale of pharmaceutical products | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
JAFCO Investment (Asia Pacific) Ltd.
JAFCO Investment (Asia Pacific) Ltd. Investment ManagersFinance JAFCO ASIA invests in companies located in the Asia Pacific region. The firm focuses on mobile and internet technology, consumer & services related, cyber security, medical/healthcare and renewable energy sectors. It participates in early and growth stage capital transactions. | Finance |
The Chinese University of Hong Kong
The Chinese University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hong Kong Institute of Financial Analysts & Professional | |
AbelZeta Pharma, Inc.
AbelZeta Pharma, Inc. BiotechnologyHealth Technology Develops cell therapies to cure cancer and inflammatory & immunological diseases | Health Technology |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ally Bridge Group HK Ltd
Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group invests in both public and private companies located in the United States, Hong Kong, Europe and China. The firm targets companies operating in the fields of healthcare, life sciences, disruptive technology platforms in both medical devices and biopharmaceuticals. It provides financing for buyout and growth stage capital requirements. It acts as a lead or co-lead investor. | Finance |
Morningside Group (Holdings) Ltd.
Morningside Group (Holdings) Ltd. Investment ManagersFinance Venture capital/private equity | Finance |
Gt Healthcare Group | |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national